Ultimaster TANSEI Stent in Complex Coronary Lesions: The EPIC08 TANSEI COMPLEX Study

Read full text Summarise with VIRAT
Authors: Ricardo Palma-Carbajal, Yassin Belahnech, José M. de la Torre Hernández, Tamara García Camarero, José Miguel Vegas Valle, Juan Rondán, Antonio Enrique Gómez Menchero, Armando Pérez de Prado, Eduardo Pinar Bermúdez, Pedro Martín Lorenzo, Jesús Jiménez Mazuecos, Koldobika García San Román
+11 more Beatriz Vaquerizo, Ramón Calviño Santos, Fernando Lozano Ruíz-Poveda, Soledad Ojeda Pineda, Jorge Perea Armijo, Jeremías Bayón, J. G. Ruigomez, Juan H. Alonso Briales, J Sanchis, Bruno García del Blanco, EPIC08 TANSEI COMPLEX Study Group
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Percutaneous coronary intervention (PCI) for complex anatomy is increasingly common. The third-generation Ultimaster TANSEI drug-eluting stent (DES) was developed to optimise safety and efficacy in challenging lesions. Methods: This was a prospective, single-arm, multicentre registry (August 2020-November 2022) of patients with complex lesions - left main, bifurcations, small vessels and long lesions - treated with Ultimaster TANSEI DES and followed for 1 year. The primary endpoint was the device-oriented composite endpoint (DoCE), including cardiac death, target-vessel MI, target-vessel revascularisation (TVR) and stent thrombosis. The secondary endpoint was the patient-oriented composite endpoint (PoCE), including all-cause death, any MI and any revascularisation. Results: In total, 501 patients with 591 complex lesions (mean age 66.7 years; 79.6% male; 33.4% with diabetes) were treated. Lesion types: left main 11%, bifurcations 43.9%, small vessels 40.7%, long lesions 34.3%. At 1 year, incidence rates were: DoCE 3.23 per 100 person-years (95% CI [1.84-5.24]) and PoCE 5.04 per 100 person-years (95% CI [3.26-7.44]). In subgroup analyses, long lesions (>35 mm) showed consistently higher risk: DoCE RR 4.22 (95% CI [1.49-11.95]; p=0.006), PoCE RR 4.93 ([2.10-11.57]; p

Fields of Study & Subjects

Coronary Interventions and Diagnostics Cardiac Imaging and Diagnostics Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
Interventional Cardiology Reviews Research Resources
Volume
21
Pages
e09–e09
Publication date
31 March 2026
Language
EN